organization · Reporting owner
LILLY ENDOWMENT INC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date May 06, 2026 · Filed May 07, 2026
Section 16 reporting ended · disclosed 2026-05-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,881,150 |
Ending reported balance
After 2026-05-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-06 · Sale · Disposed 13,620 · Balance 91,883,358 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4. Row 2 · 2026-05-06 · Sale · Disposed 2,208 · Balance 91,881,150 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 11, 2021 Filed Jan 12, 2021 16:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 128,528 | $184.87 | $23,760,585.78 |
DisclosureSEC source: 0001209191-21-003183 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,003,815 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.44 to $185.4375, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 18:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 220 | $170.32 | $37,469.96 |
DisclosureSEC source: 0001209191-20-042136 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,132,343 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.31 to $170.40, inclusive. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 18:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 12,741 | $169.68 | $2,161,922.18 |
DisclosureSEC source: 0001209191-20-042136 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,132,563 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.20 to $170.11, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 44,745 | $167.83 | $7,509,508.61 |
DisclosureSEC source: 0001209191-20-041658 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,145,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.60 to $168.26, inclusive. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 165,255 | $167.15 | $27,622,290.62 |
DisclosureSEC source: 0001209191-20-041658 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,190,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.60 to $167.595, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 24,308 | $168.36 | $4,092,567.80 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,655,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.00 to $168.91, inclusive. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 65,046 | $167.40 | $10,888,726.42 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,379,612 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.00 to $167.99, inclusive. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 18:27 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 115,646 | $166.46 | $19,250,791.66 |
DisclosureSEC source: 0001209191-20-041489 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,444,658 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.00 to $166.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 15:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 300 | $164.02 | $49,205.10 |
DisclosureSEC source: 0001209191-20-039575 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,560,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to $164.025, inclusive. Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 15:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 166,532 | $163.20 | $27,178,555.30 |
DisclosureSEC source: 0001209191-20-039575 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,560,604 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 19:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 608 | $164.04 | $99,736.32 |
DisclosureSEC source: 0001209191-20-039426 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,727,136 Read SEC document |
| June 29, 2020 Filed Jun 30, 2020 19:12 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 10,823 | $163.36 | $1,768,023.63 |
DisclosureSEC source: 0001209191-20-039426 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,727,744 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $163.84, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:48 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 31,737 | $163.01 | $5,173,403.94 |
DisclosureSEC source: 0001209191-20-039425 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,738,567 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $164.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 26, 2020 Filed Jul 1, 2020 13:55 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 31,737 | $163.01 | $5,173,403.94 |
DisclosureSEC source: 0001209191-20-039565 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,738,567 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.00 to $164.415, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,422 | $162.65 | $393,928.61 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,770,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.53 to $162.85, inclusive. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 25,544 | $162.10 | $4,140,702.84 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,772,726 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.52 to $162.50, inclusive. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 18:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 25,804 | $160.88 | $4,151,414.61 |
DisclosureSEC source: 0001209191-20-037851 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,798,270 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.50 to $161.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,488 | $163.02 | $2,687,923.22 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,824,074 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.84 to $163.385, inclusive. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 31,210 | $162.28 | $5,064,814.98 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,840,562 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.84 to $162.83, inclusive. Read SEC document |
| June 17, 2020 Filed Jun 18, 2020 21:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 113,532 | $160.90 | $18,266,731.14 |
DisclosureSEC source: 0001209191-20-037672 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,871,772 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.50 to $161.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,523 | $167.18 | $254,613.62 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,985,304 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.05 to $167.27, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 14,823 | $166.41 | $2,466,754.72 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,986,827 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.02 to $166.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,935 | $165.60 | $2,638,851.94 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,001,650 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.02 to $166.01, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,373 | $164.57 | $3,188,233.98 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,017,585 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.02 to $165.00, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 56,144 | $163.40 | $9,174,041.89 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,036,958 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.02 to $164.00, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 46,024 | $162.66 | $7,486,033.72 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,093,102 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.02 to $163.01, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 19,290 | $161.46 | $3,114,486.24 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,139,126 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.00 to $161.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 17,850 | $160.35 | $2,862,326.04 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,158,416 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.00 to $160.98, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 18,466 | $159.57 | $2,946,615.93 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,176,266 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.00 to $159.99, inclusive. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 19:13 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,909 | $158.54 | $461,186.75 |
DisclosureSEC source: 0001209191-20-037202 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,194,732 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.00 to $158.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 16:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 12,663 | $163.60 | $2,071,714.92 |
DisclosureSEC source: 0001209191-20-025889 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,197,641 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.50 to $164.14, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 4,200 | $163.99 | $688,758.00 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,210,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.685 to $164.23, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 118,958 | $163.05 | $19,396,530.15 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,214,504 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.6721 to $163.67, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 47,225 | $162.18 | $7,658,870.22 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,333,462 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.67 to $162.66, inclusive. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 49,617 | $161.22 | $7,999,059.23 |
DisclosureSEC source: 0001209191-20-025778 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,380,687 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.67 to $161.66, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 16,709 | $161.98 | $2,706,590.66 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,430,304 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.63 to $162.39, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 20,831 | $160.90 | $3,351,666.24 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,447,013 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.63 to $161.60, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 125,314 | $160.14 | $20,067,621.05 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,467,844 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.63 to $160.625, inclusive. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 14:39 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 67,146 | $159.36 | $10,700,708.86 |
DisclosureSEC source: 0001209191-20-025751 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,593,158 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.63 to $159.625, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 89,949 | $145.85 | $13,118,791.80 |
DisclosureSEC source: 0001209191-20-024193 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,660,304 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.51 to $146.30, inclusive. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:43 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 140,051 | $145.14 | $20,326,750.05 |
DisclosureSEC source: 0001209191-20-024193 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,750,253 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.51 to $145.50, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,900 | $144.69 | $274,901.50 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,890,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.50 to $144.76, inclusive. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 68,927 | $143.91 | $9,919,539.60 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,892,204 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.50 to $144.49, inclusive. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 16:49 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 101,488 | $142.70 | $14,481,840.31 |
DisclosureSEC source: 0001209191-20-023901 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,961,131 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 15:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 15,962 | $142.73 | $2,278,321.70 |
DisclosureSEC source: 0001209191-20-023707 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,062,619 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.15, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 18:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,279 | $143.68 | $902,173.00 |
DisclosureSEC source: 0001209191-20-023570 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,078,581 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.51 to $143.96, inclusive. Read SEC document |
| April 03, 2020 Filed Apr 6, 2020 18:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 20,444 | $143.04 | $2,924,319.98 |
DisclosureSEC source: 0001209191-20-023570 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,084,860 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.50 to $143.4875, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 6,132 | $142.26 | $872,350.58 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,105,304 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.69, inclusive. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 43,894 | $141.42 | $6,207,489.48 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,111,436 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.99, inclusive. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 16:42 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 116,012 | $140.46 | $16,294,813.50 |
DisclosureSEC source: 0001209191-20-023001 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,155,330 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.